ABSTRACT
Objetivo: Analizar el contenido de los diferentes estudios publicados relacionados con el ejercicio físico y sus efectos sobre la incontinencia urinaria, así como determinar la efectividad de los programas de entrenamiento de suelo pélvico. Método: Se realizó búsqueda en las bases de datos de Pubmed, CINAHL, Biblioteca Cochrane Plus y The Cochrane Library, WOS, SPORTDiscus y una búsqueda manual en el metabuscador Google Scholar de acuerdo a los descriptores de búsqueda de documentos publicados en los últimos 10 años en español o en inglés, con resumen o a texto completo, tanto del tratamiento de la incontinencia urinaria en la mujer deportista como en la mujer en general. Resultados: Se seleccionan 3 artículos a texto completo sobre el tratamiento de la incontinencia urinaria en la mujer deportista, y 6 artículos a texto completo y un resumen sobre el tratamiento de la incontinencia urinaria en la mujer en general. Los 9 estudios incluidos en la revisión obtuvieron resultados positivos, es decir, en todos ellos hubo una mejora de la enfermedad. Conclusiones: El ejercicio físico, concretamente los programas de entrenamiento de la musculatura del suelo pélvico, tienen efectos positivos sobre la incontinencia urinaria. Este tipo de entrenamiento se muestra como un programa efectivo para el tratamiento de la incontinencia urinaria, especialmente la incontinencia urinaria de esfuerzo
Objective: To analyse the content of various published studies related to physical exercise and its effects on urinary incontinence and to determine the effectiveness of pelvic floor training programmes. Method: We conducted a search in the databases of PubMed, CINAHL, the Cochrane Plus Library, The Cochrane Library, WOS and SPORTDiscus and a manual search in the Google Scholar metasearcher using the search descriptors for documents published in the last 10 years in Spanish or English. The documents needed to have an abstract or complete text on the treatment of urinary incontinence in female athletes and in women in general. Results: We selected 3 full-text articles on treating urinary incontinence in female athletes and 6 full-text articles and 1 abstract on treating urinary incontinence in women in general. The 9 studies included in the review achieved positive results, i.e., there was improvement in the disease in all of the studies. Conclusions: Physical exercise, specifically pelvic floor muscle training programmes, has positive effects on urinary incontinence. This type of training has been shown to be an effective programme for treating urinary incontinence, especially stress urinary incontinence
Subject(s)
Humans , Female , Urinary Incontinence/therapy , Pelvic Floor/physiology , Muscles/physiology , Exercise/physiology , Exercise Therapy , Perineum/physiology , Muscle Contraction/physiology , Evaluation of the Efficacy-Effectiveness of Interventions , Urinary Incontinence/therapyABSTRACT
OBJECTIVE: To analyse the content of various published studies related to physical exercise and its effects on urinary incontinence and to determine the effectiveness of pelvic floor training programmes. METHOD: We conducted a search in the databases of PubMed, CINAHL, the Cochrane Plus Library, The Cochrane Library, WOS and SPORTDiscus and a manual search in the Google Scholar metasearcher using the search descriptors for documents published in the last 10 years in Spanish or English. The documents needed to have an abstract or complete text on the treatment of urinary incontinence in female athletes and in women in general. RESULTS: We selected 3 full-text articles on treating urinary incontinence in female athletes and 6 full-text articles and 1 abstract on treating urinary incontinence in women in general. The 9 studies included in the review achieved positive results, i.e., there was improvement in the disease in all of the studies. CONCLUSIONS: Physical exercise, specifically pelvic floor muscle training programmes, has positive effects on urinary incontinence. This type of training has been shown to be an effective programme for treating urinary incontinence, especially stress urinary incontinence.
Subject(s)
Exercise Therapy , Pelvic Floor , Urinary Incontinence/therapy , Female , Humans , Treatment OutcomeABSTRACT
BACKGROUND: fibre is effective in some types of constipation. Our objective was to determine if the administration of an enriched dairy preparation with a supplement of soluble fibre (Naturfibra) [inulin and digestion resistant maltodextrin (Fibersol 2)], improves primary chronic constipation. METHODS: Prospective, randomized, double blind clinical trial randomized with dietary intervention in 32 subjects with constipation according to the Rome II criteria. Thirty two subjects (men 4; women 28) with an average age of 47 +/- 15 years were randomly divided in two homogeneous groups. A type of milk (A or B) was assigned to each group. Group A received fibre enriched semi-skimmed milk; Group B received semi skimmed milk. The subjects drank half a litre of milk per day during 20 days, meaning that those who drank the enriched milk ingested 20 grams of fibre a day. RESULTS: The subjects that presented straining at defecation (p < 0.001), sensation of incomplete evacuation (p < 0.001), sensation of obstruction in the evacuation (p < 0.001) and days between bowel movements, diminished significantly after the intake of milk supplemented with fibre. CONCLUSION: The intake of a dairy preparation with a supplement of fibre containing 20 grams of soluble fibre (inulin and digestion resistant maltodextrin), improves the situation of idiopathic primary chronic constipation based on the Rome II criteria.
Subject(s)
Constipation/diet therapy , Dietary Fiber/therapeutic use , Food, Fortified , Milk , Adult , Analysis of Variance , Animals , Chronic Disease , Constipation/diagnosis , Dietary Fiber/administration & dosage , Double-Blind Method , Energy Intake , Female , Humans , Male , Middle Aged , Prospective Studies , Time Factors , Treatment OutcomeABSTRACT
Objetivo: Determinar si la administración de un preparado lácteo enriquecido con un suplemento de fibra soluble (Naturfibra)®[inulina y maltodextrina resistente a la digestión (Fibersol 2®)], afecta a la sintomatología en el estreñimiento crónico primario idiopático. Ámbito: Sujetos de ambos sexos con estreñimiento según los criterios de Roma II. Sujetos: Se trata de un ensayo clínico doble ciego aleatorizado de intervención dietética realizado en 32 individuos con estreñimiento de ambos sexos (hombres 4; mujeres 28) y con una edad media de 47 ± 15 años. Los 32 individuos que formaban la muestra, se dividieron al azar en dos grupos homogéneos. Intervenciones: A cada grupo se le asignó un tipo de leche (A o B), una de ellas era leche semidesnatada enriquecida con fibra (A) y la otra leche semidesnatada (B). Los sujetos tomaron medio litro de leche diario durante 20 días, lo que supone que aquellos que tomaron la leche enriquecida ingirieron 20 gramos de fibra al día. Resultados: Los individuos que presentaban esfuerzo deposicional (p < 0,001), sensación de evacuación incompleta (p < 0,001), sensación de obstrucción en la evacuación (p < 0,001) y número de días entre deposiciones, disminuyeron significativamente tras la ingesta de leche con fibra. Conclusiones: La ingesta de un preparado lácteo con un suplemento de fibra que contiene 20 gramos de fibra soluble (inulina y maltodextrina resistente a la digestión), mejora la situación de estreñimiento crónico primario idiopático en base a los criterios de Roma II (AU)
Background: fibre is effective in some types of constipation. Our objective was to determine if the administration of an enriched dairy preparation with a supplement of soluble fibre (Naturfibra)® [inulin and digestion resistant maltodextrin (Fibersol 2®)], improves primary chronic constipation. Methods: Prospective, randomized, double blind clinical trial randomized with dietary intervention in 32 subjects with constipation according to the Rome II criteria. Thirty two subjects (men 4; women 28) with an average age of 47 ± 15 years were randomly divided in two homogeneous groups. A type of milk (A or B) was assigned to each group. Group A received fibre enriched semi-skimmed milk; Group B received semi skimmed milk. The subjects drank half a litre of milk per day during 20 days, meaning that those who drank the enriched milk ingested 20 grams of fibre a day. Result: The subjects that presented straining at defecation (p < 0,001), sensation of incomplete evacuation (p < 0,001), sensation of obstruction in the evacuation (p < 0,001) and days between bowel movements, diminished significantly after the intake of milk supplemented with fibre. Conclusion: The intake of a dairy preparation with a supplement of fibre containing 20 grams of soluble fibre (inulin and digestion resistant maltodextrin), improves the situation of idiopathic primary chronic constipation based on the Rome II criteria (AU)
Subject(s)
Humans , Male , Female , Constipation/diet therapy , Dietary Fiber/administration & dosage , Inulin/administration & dosage , Probiotics/administration & dosage , Polymers/therapeutic use , Milk , Nutrition SurveysABSTRACT
No disponible
No disponible
Subject(s)
Male , Female , Child , Humans , Exercise/physiology , Obesity/diagnosis , Obesity/therapy , Weight Gain , Weight Gain/physiology , Anthropometry/methods , Analysis of Variance , Densitometry/methods , Body Mass Index , Linoleic Acids, Conjugated/therapeutic use , Anthropometry/instrumentation , Diet/methods , Diet, Reducing/methods , Linoleic Acids, Conjugated/administration & dosageABSTRACT
Los pacientes con enfermedades del espectro esquizofrénico son más obesos que la media de la población. En este dato epidemiológico colabora la propia enfermedad (debido a alteraciones centrales de los neurotransmisores relacionados con la saciedad), potenciada por la acción de algunos antipsicóticos (clozapina, olanzapina, etc.). Asimismo, la mortalidad de este grupo de población es más alta que la general, y en ello tiene mucho que ver esa obesidad junto con otros factores añadidos, como la resistencia a la insulina y la hipertrigliceridemia, factores todos ellos que constituyen el llamado síndrome metabólico. En la actualidad, los estudios sobre la obesidad se están multiplicando. Se vive una situación compleja en la que todavía no se reconocen los mecanismos últimos que actúan, aunque se sabe bastante acerca de los complicados mecanismos reguladores del organismo en los que están implicados múltiples agentes (insulina, leptina, neuropéptido Y, agouty related-protein, proopiomelanocortina, cocain and amphetamine related transcript, galanina, ghrelina, endocannabinoides, betaendorfinas, encefalinas y dinorfinas, etc.). En esta revisión se estudia la acción de la enfermedad mental y de su tratamiento farmacológico sobre este intrincado funcionamiento regulador
Obesity is more frequent in patients with schizophrenia than in the general population. The illness itself plays a role in this epidemiological datum (due to alterations in central neurotransmitters related to satiety), enhanced by the action of some antipsychotic drugs (clozapine, olanzapine). Obesity is one of the factors that leads to the higher mortality found in these patients than in the general population, in addition to other factors such as insulin resistance and hypertriglyceridemia. All these factors together constitute metabolic syndrome. Studies on obesity are being published with increasing frequency. Currently, the situation is complex and the mechanisms involved remain unknown, although much is known about the bodys complex regulatory mechanisms, in which multiple agents are involved (insulin, leptin, neuropeptide Y, agouty related-protein, proopiomelanocortin, cocain and amphetamine related transcript, galanin, ghrelin, endocannabinoids, beta-endorphins, enkephalins and dynorphin). The influence of mental illness and its pharmacological treatment on this intricate regulatory function is the subject of the present review
